Turck, DominiqueBohn, TorstenCastenmiller, JacquelineDe Henauw, StefaanHirsch-Ernst, Karen IldicoMaciuk, AlexandreMangelsdorf, IngeMcArdle, Harry JNaska, AndronikiPelaez, CarmenPentieva, KristinaSiani, AlfonsoThies, FrankTsabouri, SophiaVinceti, MarcoCubadda, FrancescoFrenzel, ThomasHeinonen, MarinaMarchelli, RosangelaNeuhäuser-Berthold, MonikaPoulsen, MortenPrieto Maradona, MiguelSchlatter, Josef Rudolfvan Loveren, HenkGerazova-Efremova, KaterinaRoldán-Torres, RuthKnutsen, Helle KatrineEFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)2023-04-202023-04-202022-06-10Turck, D, Bohn, T, Castenmiller, J, De Henauw, S, Hirsch-Ernst, K I, Maciuk, A, Mangelsdorf, I, McArdle, H J, Naska, A, Pelaez, C, Pentieva, K, Siani, A, Thies, F, Tsabouri, S, Vinceti, M, Cubadda, F, Frenzel, T, Heinonen, M, Marchelli, R, Neuhäuser-Berthold, M, Poulsen, M, Prieto Maradona, M, Schlatter, J R, van Loveren, H, Gerazova-Efremova, K, Roldán-Torres, R, Knutsen, H K & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2022, 'Safety of vitamin D 2 mushroom powder as a Novel food pursuant to Regulation (EU) 2015/2283 (NF 2019/1471).', EFSA Journal, vol. 20, no. 6, e07326. https://doi.org/10.2903/j.efsa.2022.73261831-4732PubMedCentral: PMC9186149ORCID: /0000-0002-9275-9713/work/133803824https://hdl.handle.net/2164/20522Requestor: European Commission Question number: EFSA-Q-2020-00417 Correspondence: nif@efsa.europa.eu222435206engNovel Foodssafetymushroom powderAgaricus bisporusUV treatmentvitamin D2R MedicineQH301 BiologyEuropean CommissionSupplementary DataRQH301Journal article10.2903/j.efsa.2022.7326206